Launching our first IP-Token on “Understanding the role of the cGAS-STING pathway and senescence in ovarian aging”by Dr. Mario D. Cordero
LEARN MOREDr. Mario Cordero is a Principal Investigator in the Department of Molecular Biology and Biochemical Engineering at the Universidad Pablo de Olavide, Sevilla, Spain (UPO).
His research focuses on inflammasomes and ovarian aging, he has published 90 articles, 8 book chapters, 2 books, and 5 patents, being cited more than 8993 times.
He has experienced the impact of ovarian aging through his wife and publicly shares his story of using fertility techniques, which led to the conception of his daughter, whom he adores.
Intellectual Property Non-Fungible Tokens (IP-NFTs) provide a secure and immutable proof of ownership for intellectual property on-chain. These tokens ensure that the details of IP ownership are unique, transparent, and tamper-proof, enabling researchers to assert ownership, raise funds, and monetize IP.
IP Tokens (IPTs) represent fractional governance rights over the intellectual property (IP) generated. These tokens offer stakeholders a unique opportunity to participate directly in the development, decision-making, and future directions of the research.
The offer of FACC tokens will occur over a 10-day period, where members of AthenaDAO may bid as much money as they are willing to contribute. In order to bid, the bidder must lock ATH equivalent to the amount of WETH they want to bid at the time of the start of the auction. The value of the bid can be up to the maximum of their ATH holdings locked in the contract. The more ATH a bidder is willing to lock in the contract for the 365 day vesting period, the more that participants may bid during the 10-day period (minimum locking time is 365 days as per the contract). If the goal of $75,000 USD is not met, all funds will be returned to funders.
Fertility Acceleration is our movement to accelerate research that will enable fertility. The small molecules developed in this project would extend reproductive longevity by dampening inflammation in the ovaries, potentially extending the fertility window and delaying menopause. The more ATH a bidder is willing to lock in the contract for the 365 day vesting period, the more that F/ACC can do.
